AirSculpt TechnologiesAIRS -1.20%73 FCF Margin % is 13.25% as of Mar. 2026, which is 94% above its 10-year median of 6.83. GuruFocus rates AIRS with a GF Score™ of 73/100 and a GF Value™ of $3.93 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 669 Healthcare Providers & Services companies, AirSculpt Technologies ranks better than 54.26% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, AirSculpt Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AirSculpt Technologies FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AirSculpt Technologies's FCF Margin % distribution charts can be found below:
* The bar in red indicates where AirSculpt Technologies's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AirSculpt Technologies (AIRS) has a FCF Margin % of 13.25% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on AirSculpt Technologies and its competitors. This is 94% above median its historical median of 6.83. According to the industry distribution chart, AirSculpt Technologies ranks #306 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 45.7%.
Is AirSculpt Technologies' FCF Margin % too high?
AirSculpt Technologies' current FCF Margin % of 13.25% is 94% above median its 10-year median of 6.83. The Healthcare Providers & Services industry median FCF Margin % is 3.34. AirSculpt Technologies' value of 13.25% is 296.7% above this industry median. Based on the distribution chart, AirSculpt Technologies ranks #306 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, AirSculpt Technologies has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AirSculpt Technologies' FCF Margin % compare to CYH and CCRN?
According to the Healthcare Providers & Services industry distribution chart, AirSculpt Technologies ranks #306 out of 669 companies for FCF Margin %. This puts AirSculpt Technologies in the upper half of its industry. The industry median FCF Margin % is 3.34. AirSculpt Technologies' value of 13.25% is 296.7% above this benchmark. While the company's 10-year median is 6.83 vs. the industry median of 3.34, AirSculpt Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.34, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AirSculpt Technologies's current FCF Margin % of 13.25% is 296.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on AirSculpt Technologies and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AirSculpt Technologies's current FCF Margin % is 13.25%, which is 94% above median its own 10-year median of 6.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AirSculpt Technologies stock overvalued right now?
Based on GuruFocus' analysis, AirSculpt Technologies (AIRS) is currently considered Modestly Overvalued. The stock's GF Value™ is $3.93, compared to a current price of $4.55 — trading 15.8% above its estimated fair value. The current FCF Margin % is 13.25%, which is 94% above median its 10-year median of 6.83 and 296.7% above the Healthcare Providers & Services industry median of 3.34. AirSculpt Technologies' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For AirSculpt Technologies (AIRS), the current FCF Margin % is 13.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AirSculpt Technologies (AIRS) Overvalued in 2026?
Based on GuruFocus' analysis, AirSculpt Technologies stock appears to be overvalued.
The current stock price of $4.55 is trading 15.8% above its estimated GF Value™ of $3.93.
GuruFocus considers AirSculpt Technologies to be Modestly Overvalued.
Key valuation signals for AIRS:
FCF Margin %: 13.25% (94% above median its 10-year median of 6.83)
GF Value™: $3.93 vs. price of $4.55 (15.8% above fair value)
Industry Position: 296.7% above the Healthcare Providers & Services median (#306 of 669)
No single metric tells the full story. See the AIRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
73GF Score
Get the complete analysis for AIRS
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AIRS has been successfully added to your 
